10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - MSN
#Net Loss#Revenue Beat#Record High#Lower Net#Beat MSN
Life Science News
Latest updates from the biotech and pharma world
Why 10x Genomics (TXG) Stock Is Trading Up Today - Markets Financial Content
#Markets Financial#Financial Content#Today Markets#Genomics#TXG
Waters Corporation Boosts Lab Productivity and Sample Throughput with Launch of Its Charged Aerosol Detector Designed for Empower Software - MarketScreener
#Corporation Boosts#Boosts Lab#Lab Productivity#Sample Throughput#Charged Aerosol
Roche’s fenebrutinib shows best-in-disease potential in MS - European Pharmaceutical Review
#European Pharmaceutical#Pharmaceutical Review#fenebrutinib shows#Review Roche#Pharmaceutical
Is 10x Genomics Inc. stock ready for a breakout - Weekly Market Summary & AI Enhanced Trading Signals - newser.com
#Weekly Market#Market Summary#Enhanced Trading#Trading Signals#Genomics
Why 10x Genomics (TXG) Stock Is Trading Up Today - Finviz
#Today Finviz#Genomics#TXG#Stock#Trading
10x Genomics (Nasdaq: TXG) to join Wolfe Research Healthcare Conference at 11:20 a.m. ET - Stock Titan
#Wolfe Research#Research Healthcare#Healthcare Conference#join Wolfe#Genomics
10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - Yahoo Finance
#Net Loss#Revenue Beat#Yahoo Finance#Record High#Lower Net
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
#Yahoo Finance#Today Yahoo#Genomics#TXG#Stock
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 - PR Newswire
#Healthcare Conference#Wolfe Research#Research Healthcare#Genomics#Conference
Captain Lonza Henderson Jr. TUCSON NOW Interview - KOLD
#Lonza Henderson#Captain Lonza#Lonza#Henderson#TUCSON
Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena
#Phase III#Clinical Trials#Trials Arena#BTK inhibitor#Roche sizes
Artificial Intelligence at Roche Diagnostics - Emerj Artificial Intelligence Research
#Artificial Intelligence#Intelligence Research#Roche Diagnostics#Emerj Artificial#Research Artificial
10x Genomics stock hits 52-week high at 17.26 USD - Investing.com
#Genomics stock#USD Investing.com#stock hits#Genomics#USD
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech
#BTK inhibitor#Fierce Biotech#reports phase#multiple sclerosis#Roche reports
Roche Just Unleashed a Drug That Could Disrupt the Entire MS Market - Yahoo Finance
#Yahoo Finance#Market Yahoo#Finance Roche#Unleashed#Drug
Why Roche Holding Stock Popped Today - Yahoo Finance
#Roche Holding#Holding Stock#Stock Popped#Popped Today#Yahoo Finance
Roche's experimental MS drug hits main goal in one of two key trials - Reuters
#Roche experimental#drug hits#hits main#main goal#key trials
Roche’s MS tablet scores in late-stage studies - BioPharma Dive
#BioPharma Dive#tablet scores#Dive Roche#late-stage studies#Dive
Roche Rival Plunges On 'Unprecedented' Results In MS Treatment - Investor's Business Daily
#Rival Plunges#Investor Business#Business Daily#Roche Rival#Treatment Investor